A Novel Multimodal Framework for Early Detection of Alzheimers Disease Using Deep Learning

2025-08-04

AI Summary

Early diagnosis of Alzheimer’s disease (AD) remains challenging due to insidious clinical onset and limited sensitivity of unimodal biomarkers. To address this, we propose a robust multimodal deep learning framework that jointly integrates structural MRI, longitudinal cognitive assessments, and temporal biomarker measurements—while explicitly accommodating incomplete or missing data. Our method employs convolutional neural networks (CNNs) to extract spatial features from MRI, long short-term memory (LSTM) networks to model temporal dynamics in cognitive and biomarker trajectories, and an adaptive weighted fusion mechanism to harmonize heterogeneous modality-specific representations. Evaluated on the publicly available Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset, the framework achieves a +6.2% improvement in prediction accuracy for conversion from mild cognitive impairment (MCI) to AD, enabling pre-symptomatic risk stratification. It outperforms state-of-the-art unimodal and conventional multimodal approaches, and offers built-in interpretability and feasibility for clinical deployment.

Technology Category

• Machine Learning: Multimodal Learning
• Computer Vision: Multi-modal Vision
• Intelligent Robots: Multimodal Perception & Sensor Fusion

Application Category

• Graph Algorithms and Modeling for the Web: Graph neural networks and deep learning approaches for Web-related graphs
• Search and Retrieval-Augmented AI: Retrieval-Augmented Generation (RAG) and multi-modal RAG
• Semantics and Knowledge: Methods, algorithms and applications for the development of semantic models, knowledge graphs and other forms of structured data models with machine-interpretable semantics

Abstract

Alzheimers Disease (AD) is a progressive neurodegenerative disorder that poses significant challenges in its early diagnosis, often leading to delayed treatment and poorer outcomes for patients. Traditional diagnostic methods, typically reliant on single data modalities, fall short of capturing the multifaceted nature of the disease. In this paper, we propose a novel multimodal framework for the early detection of AD that integrates data from three primary sources: MRI imaging, cognitive assessments, and biomarkers. This framework employs Convolutional Neural Networks (CNN) for analyzing MRI images and Long Short-Term Memory (LSTM) networks for processing cognitive and biomarker data. The system enhances diagnostic accuracy and reliability by aggregating results from these distinct modalities using advanced techniques like weighted averaging, even in incomplete data. The multimodal approach not only improves the robustness of the detection process but also enables the identification of AD at its earliest stages, offering a significant advantage over conventional methods. The integration of biomarkers and cognitive tests is particularly crucial, as these can detect Alzheimer's long before the onset of clinical symptoms, thereby facilitating earlier intervention and potentially altering the course of the disease. This research demonstrates that the proposed framework has the potential to revolutionize the early detection of AD, paving the way for more timely and effective treatments

Problem

• Early detection of Alzheimer's Disease using multimodal data
• Improving diagnostic accuracy with deep learning techniques
• Integrating MRI, cognitive tests, and biomarkers for robustness

Innovation

• Multimodal framework integrates MRI, cognitive, biomarker data
• Uses CNN for MRI and LSTM for cognitive analysis
• Weighted averaging enhances accuracy with incomplete data